SCHEDULE 13G

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD

Filed

March 28, 2016

Accession Number

0000899140-16-001336

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →